It has been described to function as a tumour suppressor via its ability to compete with eIF4E1 for the 5′ cap with an apparent inability to interact with eIF4G (20), and as a promoter of tumourigenicity, a gain of function phenotype reminiscent of an oncogene (33,34). This evidence concerns the gene EIF4E and neoplasm.